<DOC>
	<DOCNO>NCT00127192</DOCNO>
	<brief_summary>The purpose trial determine efficacy safety investigational drug patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>A Study Investigational Drug Sitagliptin Type 2 Diabetes Mellitus ( 0431-044 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients type 2 diabetes mellitus Patients type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>